🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Pfm Health Sciences - Q4 2025 13F Filings

PF

Pfm Health Sciences, Lp

CIK: 0001442756
Address: California San Francisco 50 California Street Suite 2650
$1 B
Portfolio Value
78
Assets Held
Reporting Period: Q4 2025
Filing Status:
Active
Last Updated: 11/16/2026

Portfolio Summary (Q4 2025)

View Full Portfolio Analysis

Top Sells

Q4 2025

Asset Allocation

Stocks/ETFs
-15.94%
$972.56 M 96.96%
Options
-88.02%
$15.32 M 1.53%
Debt
-3.62%
$15.13 M 1.51%
Other
$0 0.00%

Sector Allocation (Stocks)

Pfm Health Sciences Q4 2025 Filing Summary

Pfm Health Sciences, Lp filed its 13F report for Q4 2025 on February 17, 2026. The portfolio totaled 1 B reflecting a -22.88% change from the prior quarter, spanning 78 assets. The top 10 holdings comprised 42.6% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 30 new positions and 20 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Pfm Health Sciences’s Q4 2025 Filing

Pfm Health Sciences submitted their Form 13F-HR for the Q4 2025 period on 02/17/2026. This was the only submission for the quarter.

In the Q4 2025 filing, Pfm Health Sciences reported a managed portfolio value of 1 B, consisting of 78 individual positions.

This page displays the raw filing documents. To see which stocks Pfm Health Sciences bought or sold during Q4 2025, please visit Pfm Health Sciences's Portfolio Analysis page.